(Q24247440)

19 October 2023

Bernardo Soares

series ordinal

2

author given names

B G O

author last names

Soares

1 reference

19 October 2023

Mauricio Silva de Lima

series ordinal

3

author given names

M S

author last names

Lima

1 reference

Cochrane Database of Systematic Reviews

19 October 2023

publication date

26 January 2004

0 references

published in

0 references

cites work

Controlled trial of sulpiride in chronic schizophrenic patients

2 references

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

21 January 2018

12 December 2020

A double-blind comparison of trifluperidol and trifluoperazine in acute schizophrenic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

The efficacy of electroconvulsive therapy in the treatment of schizophrenia. A comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Effects of selected phenothiazines on REM sleep in schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

High Doses of Trifluperazine and Tardive Dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Ritanserin as add-on medication to neuroleptic therapy for patients with chronic or subchronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Effects of antipsychotic drugs on memory functions of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Long-Term Prognosis and the Response of Schizophrenic Children to Drug Therapy : A Controlled Study of Trifluoperazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Disturbed chronic psychotic patients: pilot trial of stelazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Flupenthixol and trifluoperazine: a double-blind investigation in the treatment of schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Trifluoperazine: a report of a clinical trial in back ward psychotic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Effects of Chlorpromazine and Trifluoperazine on the Activity of Chronic Schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Trifluoperazine dihydrochloride (stelazine) in paranoid schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

A study of the withdrawal of chlorpromazine or trifluoperazine in chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Different Effects of Trifluoperazine when Administered Daytime or Night

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Trifluoperazine in the treatment of psychotic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Tranquilizers or Anti-Depressants for Chronic Schizophrenics: A Long Term Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

The use of stelazine and parnate in chronic, withdrawn patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Clinical trial of "stelazine" on apathetic chronic schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Efficacy of trifluoperazine in chronic mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Thiothixene and trifluoperazine in a step system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

A Comparison of the Effects of Oxypertine and Trifluoperazine in Withdrawn Schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Olanzapine for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Language bias in randomised controlled trials published in English and German.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Loxapine for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Risperidone versus typical antipsychotic medication for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Haloperidol versus placebo for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Changing patterns of neuroleptic dosage over a decade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Sulpiride for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Quetiapine for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Chlorpromazine versus placebo for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

Clozapine versus typical neuroleptic medication for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003545.PUB2

[Clinical trial of stelazine therapy in schizophrenia refractory to alternative treatments.]

21 January 2018

1 reference

12 December 2020

A controlled trial of pimozide and trifluoperazine in chronic schizophrenic syndromes

1 reference

12 December 2020

Thiothixene versus trifluoperazine in newly-admitted schizophrenic patients

1 reference

12 December 2020

Acute paranoid schizophrenia. (Treatment with chlorpromazine, trifluoperazine and placebo)

1 reference

12 December 2020

The treatment of schizophrenia with long-acting oral neuroleptics: a six-month double-blind investigation of penfluridol versus trifluoperazine

1 reference

12 December 2020

A Double-Blind Comparison of Loxapine Succinate and Trifluoperazine in Newly Admitted Schizophrenic Patients

1 reference

12 December 2020

Haloperidol--new addition to the drug treatment of schizophrenia

1 reference

12 December 2020

A comparison of thioridazine, trifluoperazine, chlorpromazine, and placebo: a double-blind controlled study on the treatment of chronic, hospitalized, schizophrenic patients

1 reference

12 December 2020

Comparison of butyrylperazine and trifluoperazine in chronic schizophrenic subjects

1 reference

12 December 2020

The effects of carphenazine, trifluoperazine and chlorpromazine on ward behavior, physiological functioning and psychological test scores in chronic schizophrenic patients

1 reference

12 December 2020

WITHDRAWAL OF LONG-TERM PHENOTHIAZINES FROM CHRONICALLY HOSPITALIZED PSYCHIATRIC PATIENTS

1 reference

12 December 2020

Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.

1 reference

12 December 2020

Efficacy of trifluoperazine on withdrawal in chronic schizophrenia

1 reference

12 December 2020

[Neuroleptics and extrapyramidal effects: correlation between antipsychotic and extrapyramidal properties]

1 reference

12 December 2020

A double-blind comparison of the acridane derivative, clomacran phosphate and trifluoperazine in schizophrenia.

1 reference

12 December 2020

A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, II

1 reference

12 December 2020

Thioridazine (mellaril) on regressed schizophrenic patients

1 reference

12 December 2020

1 reference

12 December 2020

[Comparative study of clothiapine and trifluoperazine in acute episodes of paranoid schizophrenia]

1 reference

12 December 2020

A double-blind comparative trial of loxapine and trifluoperazine in acute and chronic schizophrenic patients

1 reference

12 December 2020

High dosage trifluoperazine in schizophrenia. Comparison of the efficacy of high and usual doses of trifluoperazine in the treatment of chronic schizophrenics

1 reference

12 December 2020

High Dose Trifluoperazine Therapy in Chronic Schizophrenia

1 reference

12 December 2020

Comparison of dosage ranges of carphenazine and trifluoperazine in elderly chronic schizophrenics

1 reference

12 December 2020

Comparison of trifluoperazine and molindone in chronic schizophrenic patients

1 reference

12 December 2020

Combined drug therapy of chronic schizophrenics. Controlled evaluation of placebo, dextro-amphetamine, imipiramine, isocarboxazid and trifluoperazine added to maintenance doses of chlorpromazine

1 reference

12 December 2020

Trifluoperazine in the treatment of chronic schizophrenics

1 reference

12 December 2020

A Comparison of Two Butyrophenones with Trifluoperazine

1 reference

12 December 2020

Haloperidol in controlling the symptoms of acute psychoses. II. A double-blind evaluation of haloperidol and trifluoperazine

1 reference

12 December 2020

Effect of phenothiazines on reaction time in schizophrenics

1 reference

12 December 2020

A Controlled Study of SK&F 14336 in Acute Schizophrenia

1 reference

12 December 2020

Double Blind Comparison of Thiothixene and Trifluoperazine in Acute Schizophrenia

1 reference

12 December 2020

A double-blind comparison of pimozide vs. trifluoperazine in schizophrenic outpatients.

1 reference

12 December 2020

Pimozide: a comparative study in the treatment of chronic schizophrenic patients

1 reference

12 December 2020

Prolixin enanthate and thorazine-stelazine regimens in the treatment of schizophrenic patients. An experimental evaluation

1 reference

12 December 2020

[The place of insulin coma therapy among the current methods of treating patients with paroxysmal schizophrenia]

1 reference

12 December 2020

Stelazine (trifluoperazine) a preliminary report on a clinical trial

1 reference

12 December 2020

Clinical evaluation of a new psychotropic drug--molindone

1 reference

12 December 2020

A controlled trial on the value of prochlorperazine, trifluoperazine and intensive group treatment

1 reference

12 December 2020

A clinical comparison of molindone hydrochloride with trifluoperazine in psychotic outpatients.

1 reference

12 December 2020

Loxapine in Newly Admitted Chronic Schizophrenic Patients

1 reference

12 December 2020

Trifluoperazine: A comparison between regular and high doses

1 reference

12 December 2020

THE EFFECTS OF WITHDRAWAL OF TRIFLUOPERAZINE ON PATIENTS MAINTAINED ON THE COMBINATION OF TRANYLCYPROMINE AND TRIFLUOPERAZINE: A DOUBLE-BLIND STUDY

1 reference

12 December 2020

GP-45795: a controlled evaluation in chronic schizophrenic patients

1 reference

12 December 2020

Loxapine: a controlled evaluation in chronic schizophrenic patients

1 reference

12 December 2020

Procyclidine and benztropine methanesulfonate compared in drug induced extrapyramidal reactions

1 reference

12 December 2020

A COMPARISON OF TRANYLCYPROMINE ALONE WITH TRANYLCYPROMINE PLUS TRIFLUOPERAZINE IN THE TREATMENT OF CHRONIC OUTPATIENTS: A DOUBLE-BLIND CONTROLLED STUDY

1 reference

12 December 2020

Trifluoperazine and chlorpromazine in combination and individually

1 reference

12 December 2020

Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association

1 reference

12 December 2020

A double-blind comparison of once-a-day pimozide, trifluoperazine, and placebo in the maintenance care of chronic schizophrenic outpatients

1 reference

12 December 2020

A standard- (trifluoperazine) controlled clinical study with clomacran in newly admitted schizophrenic patients

1 reference

12 December 2020

A double-blind study of SKF 14336 vs. trifluoperazine in schizophrenic patients

1 reference

12 December 2020

A CONTROLLED EVALUATION OF BUTAPERAZINE IN CHRONIC SCHIZOPHRENIC PATIENTS

1 reference

12 December 2020

A double-blind comparison of molindone and trifluoperazine in the treatment of acute schizophrenia

1 reference

12 December 2020

Trifluperidol and Trifluoperazine in Acute Schizophrenic Patients

1 reference

12 December 2020

Selective drug action related to chronic schizophrenic subtype. (A comparative study of carphenazine, chlorpromazine, and trifluoperazine)

1 reference

12 December 2020

Thiothixene in schizophrenic psychoses

1 reference

12 December 2020

Objective evaluation of EEG amplitude in chronic schizophrenic patients during a controlled trial of pimozide and trifluoperazine.

1 reference

12 December 2020

Comparative Effects of Intramuscular Thiothixene and Trifluoperazine in Psychotic Patients

1 reference

12 December 2020

A COMPARISON OF SKF-7261 AND TRIFLUOPERAZINE (STELAZINE) IN THE TREATMENT OF CHRONIC SCHIZOPHRENIC PATIENTS

1 reference

12 December 2020

A twelve month comparison of penfluridol and trifluoperazine in chronic schizophrenic outpatients

1 reference

12 December 2020

A terminal double-blind trail of tri-fluoperazine ("stelazine") in chronic schizophrenia

1 reference

12 December 2020

THE NURSES' OBSERVATION SCALE FOR INPATIENT EVALUATION: A NEW SCALE FOR MEASURING IMPROVEMENT IN CHRONIC SCHIZOPHRENIA

1 reference

12 December 2020

Detecting skewness from summary information

1 reference

12 December 2020

Clinical pharmacology of the phenothiazines

1 reference

12 December 2020

Molindone: a controlled evaluation in chronic schizophrenic patients

1 reference

12 December 2020

Preliminary observations on trifluoperazine in schizophrenia

1 reference

12 December 2020

A controlled clinical trial of trifluperidol on a group of chronic schizophrenic patients

1 reference

12 December 2020

A double-blind comparison of loxitane--loxapine succinate and trifluoperazine hydrochloride in chronic schizophrenic patients

1 reference

12 December 2020

A simple and reliable subclassification of chronic schizophrenia

1 reference

12 December 2020

Comparison of thiopropazate and trifluoperazine on oral dyskinesia - a double blind study

1 reference

12 December 2020

Psychopharmacologic characteristics of an indole compound--molindone

1 reference

12 December 2020

The position of trifluoperazine in the group of neuroleptics (a controlled clinical comparative study)

1 reference

12 December 2020

The clinical effects of intramuscular thiothixene and trifluoperazine in chronic schizophrenia: a comparative study

1 reference

12 December 2020

A COMPARATIVE STUDY OF OXYPERTINE AND TRIFLUOPERAZINE IN CHRONIC SCHIZOPHRENIA--A NEW APPLICATION OF THE WING RATING SCALE

1 reference

12 December 2020

A comparison of haloperidol and Trifluoperazine. (A double-blind, controlled study on chronic schizophrenic outpatients)

1 reference

12 December 2020

A comparative study of molindone and trifluoperazine

1 reference

12 December 2020

A Comparison of Fluspirilene and Trifluoperazine in the Treatment of Acute Schizophrenic Psychosis

1 reference

12 December 2020

A COMPARISON OF PARGYLINE AND TRANYLCYPROMINE WITH AND WITHOUT THE ADDITION OF TRIFLUOPERAZINE: A DOUBLE-BLIND STUDY

1 reference

12 December 2020

Centbutindole vs trifluoperazine: a double-blind controlled clinical study in acute schizophrenia

1 reference

12 December 2020

ARE TRANQUILIZER COMBINATIONS MORE EFFECTIVE THAN A SINGLE TRANQUILIZER?

1 reference

12 December 2020

A double-blind trial to investigate the effects of Thorazine (Largactil, chlorpromazine), Compazine (Stemetil, prochlorperazine) and Stelazine (trifluoperazine) in paranoid schizophrenia

1 reference

12 December 2020

Chlorpromazine, trifluoperazine and placebo with long-term mental hospital patients

1 reference

12 December 2020

A comparative study of fluphenazine enanthate and trifluoperazine in chronic schizophrenic patients.

1 reference

12 December 2020

A comparison of the effectiveness of trifluoperazine and chlorpromazine in schizophrenia

1 reference

12 December 2020

Treatment of hospitalized schizophrenics with trifluoperazine plus tranylcypromine: a double-blind controlled study

1 reference

12 December 2020

A double-blind comparison of the onset of activity of haloperidol and trifluoperazine

1 reference

12 December 2020

A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, I

1 reference

12 December 2020

Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.

1 reference

12 December 2020

A comparison of an acridan derivative (Smith Kline and French 14336) and trifluoperazine in the treatment of chronic schizophrenia

1 reference

12 December 2020

Comparative short-term evaluation of penfluridol and trifluoperazine in chronic schizophrenia

1 reference

12 December 2020

Management of behavioral symptoms in disturbed elderly patients: comparison of trifluoperazine and haloperidol.

1 reference

12 December 2020

Thiothixene: a controlled evaluation of the intramuscular antipsychotic preparation

1 reference

12 December 2020

Comparison of methylperidol and trifluoperazine in the treatment of chronic, underactive schizophrenic patients

1 reference

12 December 2020

[Comparative studies of the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia]

1 reference

12 December 2020

Differential drug effects of two phenothiazines. (A controlled comparison of thioridazine and trifluoperazine in chronic schizophrenics)

1 reference

12 December 2020

Management of hostile, suspicious patients. Trifluoperazine versus haloperidol.

1 reference

12 December 2020

Trifluoperazine in chronic, withdrawn schizophrenics

1 reference

12 December 2020

The psychopharmacology of phenothiazine compounds: a comparative study of the effects of chlorpromazine, promethazine, trifluoperazine and perphenazine in normal males. I. Introduction, aims and methods

1 reference

12 December 2020

A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia

1 reference

12 December 2020

EFG activation of patients receiving phenothiazines and chlordiazepoxide.

1 reference

12 December 2020

10.1002/14651858.CD003545.PUB2

Identifiers

DOI

0 references

Fatcat ID

release_ba4momlakzbvphpqfgiztmwyj4

0 references

PMC publication ID

7003674

0 references